和铂医药“惊天”NewCo交易背后的深意

钛媒体
Jan 11, 2025

文 | 医曜TSLP靶点是时下最火热的医药赛道之一,GSK不惜为其豪掷10亿美元;NewCo是如今最火热的医药融资方式,几乎所有药企都希望能够通过NewCo破局。当最火热的赛道,碰上最火热的融资方式,两者又会擦出怎样的火花呢?和铂医药就完成了一项如此引人瞩目的交易。1月10日,和铂医药与科伦博泰联合宣布,与Windward Bio AG(以下简称“Windward Bio”)完成了一项资本交易。...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10